mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.01 |
mRNA |
bafilomycin A1 |
CTRPv2 |
pan-cancer |
AAC |
0.34 |
0.01 |
mRNA |
JW-480 |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.02 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.02 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.02 |
mRNA |
MLN2238 |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.02 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.02 |
mRNA |
KPT185 |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.02 |
mRNA |
BRD-K71781559 |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.02 |
mRNA |
RITA |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.02 |